uniQure N.V. (NASDAQ: QURE) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT UNIQURE N.V.

uniQure N.V. (NASDAQ: QURE)
Listen to this Section


$28.90
+2.1350 ( +7.98% ) 1.6M

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Clinical Trial Pipeline Stages


Drug Name Stage
HEMGENIX® (etranacogene dezaparvovec-drlb) (AMT-061)DetailsHemophilia, Rare diseases, Rare genetic disease Approved
AMT-191DetailsFabry disease, Genetic disorder Phase 1/2
AMT-130DetailsHuntington's disease, Genetic disorder Phase 1/2
AMT-260DetailsEpilepsy, Mesial temporal lobe epilepsy Phase 1/2
AMT-162DetailsAmyotrophic lateral sclerosis Phase 1/2

Market Data


Open $28.90
Previous Close $26.76
Volume 1.6M
Market Cap $1.69B
Day Range $26.72 - $29.36
52 Week Range $8.73 - $71.50
Shares Outstanding 63.07M
Change % +7.98%
Net Change ▲ 2.1350
Insider Ownership -0.01%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2014
CountryNetherlands
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -477,017.00

Date Type Amount Purchased Purchaser
2024-06-18 Sale -2222.00 POST LEONARD E
2024-06-17 Sale -2218.00 Kaye Jack
2024-06-17 Sale -4781.00 Potts Jeannette
2024-06-17 Sale -2231.00 Springhorn Jeremy P.
2024-06-17 Sale -2229.00 Meek David D.
2024-06-17 Sale -2231.00 Balachandran Madhavan
2024-06-17 Sale -2220.00 Soteropoulos Paula
2024-06-17 Sale -3504.00 Gut Robert
2024-06-17 Sale -2221.00 Jacques Rachelle Suzanne
2024-03-05 Sale -49500.00 Abi-Saab Walid

SEC Filings


Form Type Description Pages Date
schedule Other 1 Nov 14, 2025
schedule Other 1 Nov 14, 2025
8-k 8K-related 14 Nov 10, 2025
10-q Quarterly Reports 77 Nov 10, 2025
4 Insider transactions 1 Nov 10, 2025
4 Insider transactions 1 Nov 06, 2025
8-k 8K-related 14 Nov 03, 2025
8-k 8K-related 21 Sep 29, 2025
4 Insider transactions 1 Sep 26, 2025
4 Insider transactions 1 Sep 26, 2025

Latest News


× Before browsing our site, please accept our cookies policy